My research focuses on the skin microbiota and the pathogenic mechanisms that lead to dysbiosis in prevalent dermatological conditions, including acne, atopic dermatitis, ulcers, and skin and soft tissue infections. A key aspect of my work involves exploring how probiotics and other topical compounds can modulate the skin microbiota, aiming to discover new intervention strategies that restore microbial balance and enhance skin health. This could open avenues for novel preventive and therapeutic approaches for common and severe skin ailments.
Additionally, my investigations extend to antibiotic resistance mechanisms, particularly in onco-hematological patient care. I am also engaged in elucidating the pathogenetic roles of chronic biofilm-related infections and examining how these infections develop and persist. My research studies the structural characteristics of biofilms and the mechanisms by which they confer antimicrobial resistance/tolerance. By developing advanced methods to assess biofilm formation and behavior, I aim to propose innovative diagnostic tools and therapeutic strategies that can more effectively improve clinical outcomes. This integrated approach underscores my commitment to advancing the field of bacteriology and contributing valuable insights into microbial dynamics and disease management.